Cellosaurus logo
expasy logo

Cellosaurus rCalu-6 (CVCL_F0Q6)

[Text version]
Cell line name rCalu-6
Accession CVCL_F0Q6
Resource Identification Initiative To cite this cell line use: rCalu-6 (RRID:CVCL_F0Q6)
Comments Population: Caucasian.
Characteristics: Can be maintained in the presence of 20 muM of 5-fluorouracil. Shows cross-resistance to 5'-deoxy-5-fluorouridine (5'-DFUR), oxaliplatin (L-OHP) and cisplatin (PubMed=28273808).
Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
Cell type: Epithelial cell; CL=CL_0000066.
Sequence variations
  • Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Lys (c.180_181TC>CA) (c.180_181delinsCA); Zygosity=Heterozygous (from parent cell line).
  • Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
Disease Lung adenocarcinoma (NCIt: C3512)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0236 (Calu-6)
Sex of cell Female
Age at sampling 61Y
Category Cancer cell line
Publications

PubMed=28273808; DOI=10.3390/ijms18030547; PMCID=PMC5372563
Annapina Russo, Assunta Saide, Silvia Smaldone, Raffaella Faraonio, Giulia Russo;
Role of uL3 in multidrug resistance in p53-mutated lung cancer cells.
Int. J. Mol. Sci. 18:547.1-547.16(2017)

Entry history
Entry creation14-Aug-2025
Last entry update14-Aug-2025
Version number1